Cargando…

Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases

There is a need to disentangle the etiological puzzle of age-related neurodegenerative diseases, whose clinical phenotypes arise from known, and as yet unknown, pathways that can act distinctly or in concert. Enhanced sub-phenotyping and the identification of in vivo biomarker-driven signature profi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Heather, Politis, Marios, Rabiner, Eugenii A., Middleton, Lefkos T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761606/ https://www.ncbi.nlm.nih.gov/pubmed/33276490 http://dx.doi.org/10.3390/cells9122581

Ejemplares similares

Dementia spectrum disorders: lessons learnt from decades with PET research
por: Wilson, Heather, et al.
Publicado: (2019)

Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
por: McCluskey, Stuart P., et al.
Publicado: (2019)

Imaging of Microglia in Patients with Neurodegenerative Disorders
por: Politis, Marios, et al.
Publicado: (2012)

O5.5. THE NEUROBIOLOGY OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: MULTI-MODAL PET AND FMRI FINDINGS
por: Howes, Oliver, et al.
Publicado: (2020)

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Pagano, Gennaro, et al.
Publicado: (2017)

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism
por: Niccolini, Flavia, et al.
Publicado: (2016)

Identifying improved TSPO PET imaging probes through biomathematics: The impact of multiple TSPO binding sites in vivo
por: Guo, Qi, et al.
Publicado: (2012)

Relevance of biomarkers across different neurodegenerative
por: Ehrenberg, Alexander J., et al.
Publicado: (2020)

Development of the CHARIOT Research Register for the Prevention of Alzheimer’s Dementia and Other Late Onset Neurodegenerative Diseases
por: Larsen, Mark E., et al.
Publicado: (2015)

Molecular Imaging Markers to Track Huntington’s Disease Pathology
por: Wilson, Heather, et al.
Publicado: (2017)

Adenosine A(2A) receptor in schizophrenia: an in vivo brain PET imaging study
por: Marques, Tiago Reis, et al.
Publicado: (2021)

The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia
por: Arumuham, Atheeshaan, et al.
Publicado: (2023)

Current status of PET imaging in Huntington’s disease
por: Pagano, Gennaro, et al.
Publicado: (2016)

Editorial: Biomarkers to Disentangle the Physiological From Pathological Brain Aging
por: Guerini, Franca Rosa, et al.
Publicado: (2020)

Boosting the diagnostic power of amyloid-β PET using a data-driven spatially informed classifier for decision support
por: Venkataraman, Ashwin V., et al.
Publicado: (2021)

Correction to: Relevance of biomarkers across different neurodegenerative diseases
por: Ehrenberg, Alexander J., et al.
Publicado: (2020)

Research Evidence of the Role of the Glymphatic System and Its Potential Pharmacological Modulation in Neurodegenerative Diseases
por: Verghese, Joji Philip, et al.
Publicado: (2022)

Disease-related patterns of in vivo pathology in Corticobasal syndrome
por: Niccolini, Flavia, et al.
Publicado: (2018)

Editorial: Biomarkers to disentangle the physiological from pathological brain aging, volume II
por: Guerini, Franca Rosa, et al.
Publicado: (2022)

Ageing, Cellular Senescence and Neurodegenerative Disease
por: Kritsilis, Marios, et al.
Publicado: (2018)

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
por: Werry, Eryn L., et al.
Publicado: (2019)

Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
por: Cerami, Chiara, et al.
Publicado: (2017)

Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [(11)C]-carfentanil PET and fMRI study
por: Shatalina, Ekaterina, et al.
Publicado: (2023)

Disentangling the personality pathways to well-being
por: Moreira, Paulo A. S., et al.
Publicado: (2023)

A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?
por: Beach, Thomas G.
Publicado: (2017)

Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [(11)C]PHNO PET
por: Rabiner, Eugenii A., et al.
Publicado: (2021)

Molecular mechanisms of proteinopathies across neurodegenerative disease: a review
por: Marsh, Alexander P.
Publicado: (2019)

Disentangling the Bidirectional Relationships Across the Corporate Sustainable Development Indicators
por: Kyaw, Khine, et al.
Publicado: (2022)

Neuroimaging of Sleep Disturbances in Movement Disorders
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Quantification of human brain PDE4 occupancy by GSK356278: A [(11)C](R)-rolipram PET study
por: van der Aart, Jasper, et al.
Publicado: (2017)

Translocator protein PET imaging in temporal lobe epilepsy: A reliable test-retest study using asymmetry index
por: Mahmud, Mohammad, et al.
Publicado: (2023)

Disentangling the multigenic and pleiotropic nature of molecular function
por: Stoney, Ruth A, et al.
Publicado: (2015)

Disentangling Aging and Mood Effects on Emotional Memory
por: Tamera, Kylee, et al.
Publicado: (2022)

The functional connectivity of language network across the life span: Disentangling the effects of typical aging from Alzheimer’s disease
por: Rafiq, Marie, et al.
Publicado: (2022)

Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
por: Doroszkiewicz, Julia, et al.
Publicado: (2022)

Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases
por: Negi, Deepika, et al.
Publicado: (2023)

Editorial: Molecular biomarkers in the prediction, diagnosis, and prognosis of neurodegenerative diseases
por: Xu, Yuzhen, et al.
Publicado: (2023)

PET and the multitracer concept in the study of neurodegenerative diseases
por: Engler, Henry, et al.
Publicado: (2015)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rhotaq5tmeoh7lkpv7e7528ejt